The idea of eating plants is, well, a bit like eating candy.
But what if you could do it on a bigger scale?
We’ve been looking at the possibility of using edible plants to treat ailments for decades, and it’s become clear that a plant-based diet can have a wide range of health benefits, from relieving pain to helping fight infections.
What if you had a way to eat more than just sugar?
That’s what the University of Texas at Austin and the University at Buffalo have created with the creation of a botanical edible that uses plant proteins.
In fact, it’s a botanically designed plant that’s actually edible.
The team, led by Dr. Michael R. Breslin, a botany professor at the university, has developed a plant that has the ability to be ingested and digested in the stomach, giving it the ability not only to help alleviate symptoms, but also to be consumed by the body.
The new botanical plant, called a chytrid, is being developed to treat digestive disorders such as Crohn’s disease, Crohns disease-related diarrhea and ulcerative colitis.
It’s one of the first botanical-based edible foods that can be eaten, and the research is being supported by the National Institutes of Health (NIH).
The botanical chybacterium, named after a Greek word meaning “chytridiomycetes,” was developed to help fight Crohn´s disease.
The plant has been used for thousands of years, first by Ancient Greeks and Romans, and later by the Chinese and Romans.
Researchers in the U.S. have been looking for an edible that would help with gastrointestinal problems, especially ulcerations.
Dr. Balslin, who is a member of the Department of Botany, said the research was designed to explore the plant’s ability to digest food.
He said the team initially found that the plant was able to digest glucose, fructose, and other sugars in the gastrointestinal tract.
The chychtrid’s ability was then investigated in mice, and researchers found that it was able, in fact, to digest the sugar it needed to be digested, Balsly’s team reported in the journal Nature.
The researchers then tested it on people with digestive problems, and found that consuming chybachid bacteria was able reduce their symptoms of Crohn sx by up to 60%.
In addition to the gastrointestinal problems the researchers were interested in, the researchers also studied the effects of the chyba plant on the immune system.
The Chyba Botanical Digestive Extract is an edible with a unique way of breaking down carbohydrates into glucose and fructose.
The scientists said it was the first edible to have the ability of digesting glucose, but it could also break down fructose, which is more stable than glucose, which can be digestible.
The digestive enzyme that the chyztrid is made of is called a glucosamine-rich polypeptide, or GPRP.
The GPRPs are present in most plants, including many that grow in nature.
Bains said that the new chybitid may not be the only edible that can help relieve digestive problems.
It could also be the first that can do it without using any chemicals.
“The GPRPG is a very small molecule, but if it was just a molecule it would have been impossible to make,” he said.
“But it’s made of protein, and that protein interacts with the digestive system, and there’s some research that indicates that the GPRPP can act as a natural anti-inflammatory compound.”
Bains added that it could be possible that there are other beneficial effects to consuming the chypbacteric extract.
He noted that, in general, he thinks that eating plants like the chytchophan plant and the chubaracteric plant is an ideal way to get a plant to do what it is meant to do, which involves breaking down sugar and fructose into sugars that the body can use to fuel energy.
The research is currently under review.
Binsley said he and his team are working on developing a more complete chybinomycete botanical extract that could be more potent, though he emphasized that it would need to be administered orally.
“I think there are a lot of questions that need to get answered about how this [chewable] plant would work,” Binsly said.
And he said he was looking forward to hearing more about the research.